Citrus Bergamot Blood Pressure Meta-analysis: What the Evidence Says

Quick Answer

Citrus Bergamot Blood Pressure Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 systematic review, 1 narrative review.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Data extraction was performed independently by two reviewers, and risk of bias was assessed using the Cochrane RoB tool. [Pehlivan S (2026); evidence level 1]
• Aromatherapy significantly reduced anxiety (SMD = − 0.46, 95% CI [–0.63, − 0.30], p < 0.00001), pain (SMD = − 1.29, 95% CI [–1.70, − 0.88], p < 0.00001), fatigue (SMD = − 0.79, 95% CI [–1.52, − 0.07], p = 0.03), and systolic (MD = − 3.72, 95% CI [–6.78, − 0.67], p = 0.02) and diastolic blood pressure (MD = − 2.30, 95% CI [–3.67, − 0.92], p = 0.001). [Pehlivan S (2026); evidence level 1]
• Epidemiological studies indicate that CRS affects a substantial proportion of patients, with an estimated prevalence of up to 0.4% in the general population and 2-3% in individuals with diabetes and heart failure, and is associated with increased morbidity and mortality. [Carollo Caterina (2026); evidence level 3]
• Most preclinical studies investigating polyphenolic interventions have focused on type IV and type V CRS, particularly diabetes-induced chronic kidney disease with associated cardiovascular dysfunction. [Carollo Caterina (2026); evidence level 3]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For citrus bergamot blood pressure meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Pehlivan S (2026). The effectiveness of aromatherapy interventions on psychological, physiological and academic outcomes in nursing and health sciences students: a meta-analysis.. DOI: 10.1186/s12909-025-08537-1. PMCID: PMC12869969. PMID: 41495795. https://pmc.ncbi.nlm.nih.gov/articles/PMC12869969/
• Carollo Caterina (2026). Nature&#8217;s Bioactives in Cardiorenal Syndrome: Polyphenols at the Crossroads&#8212;Preclinical Insights into Redox, Inflammation, and Mitochondrial Protection. DOI: 10.3390/nu18060955. PMCID: PMC13028789. PMID: 41901130. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13028789/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.